These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 22782961)

  • 21. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
    Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
    N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
    Tung CF; Yang DY; Hu WH; Peng YC; Chow WK; Chen GH
    Hepatogastroenterology; 2003; 50(53):1564-8. PubMed ID: 14571787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National antiviral treatment program and the incidence of hepatocellular carcinoma and associated mortality in Taiwan: a preliminary report.
    Chang CH; Lin JW; Wu LC; Liu CH; Lai MS
    Med Care; 2013 Oct; 51(10):908-13. PubMed ID: 23969591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
    Chang MH; Chen CJ; Lai MS; Hsu HM; Wu TC; Kong MS; Liang DC; Shau WY; Chen DS
    N Engl J Med; 1997 Jun; 336(26):1855-9. PubMed ID: 9197213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and etiologic features of hepatocarcinoma in Sicily].
    Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
    Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
    Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
    Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex difference for urologic malignancy risk in uremic patients after kidney transplantation: a population-based study.
    Hwang JC; Jiang MY; Lu YH; Weng SF
    Transplantation; 2015 Apr; 99(4):818-22. PubMed ID: 25208323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
    Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
    Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: the changing epidemiology of hepatocellular carcinoma in Canada.
    Dyer Z; Peltekian K; van Zanten SV
    Aliment Pharmacol Ther; 2005 Jul; 22(1):17-22. PubMed ID: 15963075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.
    Chien YC; Jan CF; Chiang CJ; Kuo HS; You SL; Chen CJ
    Hepatology; 2014 Jul; 60(1):125-32. PubMed ID: 24497203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
    Ikeda K; Saitoh S; Koida I; Arase Y; Tsubota A; Chayama K; Kumada H; Kawanishi M
    Hepatology; 1993 Jul; 18(1):47-53. PubMed ID: 7686879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.